Russell Investments Group’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
VCM
GC
Russell Investments Group's FLNA Position: Q1 2026 in Review
Russell Investments Group reduced its Filana Therapeutics (FLNA) stake by 10% in Q1 2026, selling an estimated $1.67K and leaving 7,320 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3748.
Russell Investments Group first reported a position in FLNA in Q1 2021 and has held it in 20 quarters since. The position peaked at $7.17M in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.
- Russell Investments Group held 7,320 shares of Filana Therapeutics worth $12.4K as of Q1 2026.
- Russell Investments Group sold 813 Filana Therapeutics shares in Q1 2026, an estimated $1.67K.
- Filana Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3748 holding.
- Russell Investments Group first reported a position in Filana Therapeutics in Q1 2021 and has held it in 20 quarters since.
- Russell Investments Group's Filana Therapeutics position peaked at $7.17M in Q2 2021.
- 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.
Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.